Emergency and Trauma Centre, Alfred Health, Melbourne, Victoria, Australia.
School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Emerg Med Australas. 2021 Feb;33(1):114-124. doi: 10.1111/1742-6723.13651. Epub 2020 Oct 19.
The aim of the present study was to describe the epidemiology and clinical features of patients presenting to the ED with suspected and confirmed COVID-19.
The COVID-19 ED (COVED) Project is an ongoing prospective cohort study in Australian EDs. This analysis presents data from eight sites across Victoria and Tasmania for July 2020 (during Australia's 'second wave'). All adult patients who met criteria for 'suspected COVID-19' and underwent testing for SARS-CoV-2 in the ED were eligible for inclusion. Study outcomes included a positive SARS-CoV-2 test result and mechanical ventilation.
In the period 1 July to 31 July 2020, there were 30 378 presentations to the participating EDs and 2917 (9.6%; 95% confidence interval 9.3-9.9) underwent testing for SARS-CoV-2. Of these, 50 (2%) patients returned a positive result. Among positive cases, two (4%) received mechanical ventilation during their hospital admission compared to 45 (2%) of the SARS-CoV-2 negative patients (odds ratio 1.7, 95% confidence interval 0.4-7.3; P = 0.47). Two (4%) SARS-CoV-2 positive patients died in hospital compared to 46 (2%) of the SARS-CoV-2 negative patients (odds ratio 1.7, 95% confidence interval 0.4-7.1; P = 0.49). Strong clinical predictors of a positive SARS-CoV-2 result included self-reported fever, non-smoking status, bilateral infiltrates on chest X-ray and absence of a leucocytosis on first ED blood tests (P < 0.05).
In this prospective multi-site study from July 2020, a substantial proportion of ED patients required SARS-CoV-2 testing, isolation and enhanced infection prevention and control precautions. Presence of SARS-CoV-2 on nasopharyngeal swab was not associated with death or mechanical ventilation.
本研究旨在描述因疑似和确诊 COVID-19 而到急诊科就诊的患者的流行病学和临床特征。
COVID-19 急诊科(COVED)项目是一项正在澳大利亚急诊科进行的前瞻性队列研究。本分析报告了 2020 年 7 月维多利亚州和塔斯马尼亚州 8 个地点的数据(正值澳大利亚“第二波”期间)。所有符合“疑似 COVID-19”标准并在急诊科接受 SARS-CoV-2 检测的成年患者均符合纳入标准。研究结果包括 SARS-CoV-2 检测阳性结果和机械通气。
在 2020 年 7 月 1 日至 7 月 31 日期间,参与急诊科共接诊 30378 例患者,其中 2917 例(9.6%;95%置信区间 9.3-9.9)接受了 SARS-CoV-2 检测。其中,50 例(2%)患者的检测结果呈阳性。在阳性病例中,有 2 例(4%)在住院期间接受了机械通气,而 SARS-CoV-2 阴性患者中则有 45 例(2%)(比值比 1.7,95%置信区间 0.4-7.3;P=0.47)。有 2 例(4%)SARS-CoV-2 阳性患者在住院期间死亡,而 SARS-CoV-2 阴性患者中则有 46 例(2%)(比值比 1.7,95%置信区间 0.4-7.1;P=0.49)。SARS-CoV-2 检测结果阳性的强烈临床预测因素包括自述发热、不吸烟状态、胸部 X 线双侧浸润和首次急诊科血液检查无白细胞增多(P<0.05)。
在这项 2020 年 7 月的前瞻性多地点研究中,相当一部分急诊科患者需要进行 SARS-CoV-2 检测、隔离和加强感染预防和控制措施。鼻咽拭子上存在 SARS-CoV-2 与死亡或机械通气无关。